Interview with Andrew Evans at the Melanoma Patient Network Europe Rare 2017 conference. 

The Power in Numbers


In a brief interview, Andrew Evans, patient advocate, who is a member of MPNE and of our Scientific Advisory board, discusses his view on the importance of having a united community specially when dealing with rare diseases.

Being uveal melanoma a rare disease, patient organisations face an additional barrier of having to unite patients from different countries. Andrew highlights the importance of numbers and the power a larger community has not only when it comes to stastical visibility but also in driving regulatory changes.